BIIB vs NXDR · P/E 21, rev $9.89B vs rev $257.6M
Biogen Inc (BIIB) versus NXDR (NXDR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
NXDR (NXDR) is a internet content & information company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported NXDR revenue for 2025-12-31 was $257.6M. Net income was -$54.2M. NXDR currently screens at market cap $833.3M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. NXDR currently screens at market cap $833.3M.
Not investment advice. Open the BIIB and NXDR stock pages for the full models.
Not investment advice.